Select your Country or Region

  • TargetMol | Compound LibraryArgentinaArgentina
  • TargetMol | Compound LibraryAustraliaAustralia
  • TargetMol | Compound LibraryAustriaAustria
  • TargetMol | Compound LibraryBelgiumBelgium
  • TargetMol | Compound LibraryBrazilBrazil
  • TargetMol | Compound LibraryBulgariaBulgaria
  • TargetMol | Compound LibraryCroatiaCroatia
  • TargetMol | Compound LibraryCyprusCyprus
  • TargetMol | Compound LibraryCzechCzech
  • TargetMol | Compound LibraryDenmarkDenmark
  • TargetMol | Compound LibraryEgyptEgypt
  • TargetMol | Compound LibraryEstoniaEstonia
  • TargetMol | Compound LibraryFinlandFinland
  • TargetMol | Compound LibraryFranceFrance
  • TargetMol | Compound LibraryGermanyGermany
  • TargetMol | Compound LibraryGreeceGreece
  • TargetMol | Compound LibraryHong KongHong Kong
  • TargetMol | Compound LibraryHungaryHungary
  • TargetMol | Compound LibraryIcelandIceland
  • TargetMol | Compound LibraryIndiaIndia
  • TargetMol | Compound LibraryIrelandIreland
  • TargetMol | Compound LibraryIsraelIsrael
  • TargetMol | Compound LibraryItalyItaly
  • TargetMol | Compound LibraryJapanJapan
  • TargetMol | Compound LibraryKoreaKorea
  • TargetMol | Compound LibraryLatviaLatvia
  • TargetMol | Compound LibraryLebanonLebanon
  • TargetMol | Compound LibraryMalaysiaMalaysia
  • TargetMol | Compound LibraryMaltaMalta
  • TargetMol | Compound LibraryMoroccoMorocco
  • TargetMol | Compound LibraryNetherlandsNetherlands
  • TargetMol | Compound LibraryNew ZealandNew Zealand
  • TargetMol | Compound LibraryNorwayNorway
  • TargetMol | Compound LibraryPolandPoland
  • TargetMol | Compound LibraryPortugalPortugal
  • TargetMol | Compound LibraryRomaniaRomania
  • TargetMol | Compound LibrarySingaporeSingapore
  • TargetMol | Compound LibrarySlovakiaSlovakia
  • TargetMol | Compound LibrarySloveniaSlovenia
  • TargetMol | Compound LibrarySpainSpain
  • TargetMol | Compound LibrarySwedenSweden
  • TargetMol | Compound LibrarySwitzerlandSwitzerland
  • TargetMol | Compound LibraryTaiwan,ChinaTaiwan,China
  • TargetMol | Compound LibraryThailandThailand
  • TargetMol | Compound LibraryTurkeyTurkey
  • TargetMol | Compound LibraryUnited KingdomUnited Kingdom
  • TargetMol | Compound LibraryUnited StatesUnited States
  • TargetMol | Compound LibraryOther CountriesOther Countries
Shopping Cart
  • Remove All
  • TargetMol
    Your shopping cart is currently empty
Filter
Applied FilterClear all
TargetMol | Tags By Target
  • AMPK
    (4)
  • Antibacterial
    (5)
  • Antifection
    (12)
  • Antioxidant
    (7)
  • Apoptosis
    (8)
  • Caspase
    (5)
  • Endogenous Metabolite
    (5)
  • c-Fms
    (5)
  • c-Met/HGFR
    (8)
  • Others
    (794)
Filter
Search Result
Results for "

13c c16 sphingomyelin

" in TargetMol Product Catalog
  • Inhibitors & Agonists
    1055
    TargetMol | Activity
  • Peptide Products
    75
    TargetMol | inventory
  • Dye Reagents
    10
    TargetMol | natural
  • PROTAC Products
    19
    TargetMol | composition
  • Natural Products
    468
    TargetMol | Activity
  • Recombinant Protein
    137
    TargetMol | inventory
  • Isotope Products
    5
    TargetMol | natural
13C C16 Sphingomyelin (d18:1/16:0)
T36149144236-99-7
13C C16 Sphingomyelin is an isotopically enriched form of C16 sphingomyelin with carbon-13 occurring on the fatty acid portion. It is intended for use as an internal standard for the quantification of C16 sphingomyelin by GC- or LC-MS. C16 Sphingomyelin is a form of sphingomyelin containing palmitate (16:0) at the variable acylation position. It is the most common form of sphingomyelin found in eggs and is less abundant in the brain and in milk. C16 Sphingomyelin interacts with cholesterol in ordered lipid domains (lipid rafts). Sphingomyelinases remove phosphorylcholine from C16 sphingomyelin to produce C16 ceramide. While ceramides commonly induce apoptosis, ceramides with different fatty acid chain lengths might direct distinct functions and, in some cases, reduce apoptosis.
  • $464
Backorder
Size
QTY
Gemcitabine EP Impurity C-13C-15N2
TMIJ-01901233921-75-9
Gemcitabine EP Impurity C-13C-15N2 is the 13C and 15N labeled compound of Gemcitabine EP Impurity C.
  • Inquiry Price
20 days
Size
QTY
Sulindac EP Impurity C-d3
TMIJ-0273250608-66-3
Sulindac EP Impurity C-d3 is a deuterated compound of Sulindac EP Impurity C. Sulindac EP Impurity C has a CAS number of 32004-67-4. (E/Z)-Sulindac sulfide is a potent γ-secretase modulator (GSM) that selectively reduces Aβ42 production in favor of shorter Aβ species. (E/Z)-Sulindac sulfide can be used for researching Alzheimer’s disease [1].
  • Inquiry Price
20 days
Size
QTY
Oseltamivir EP Impurity C-d3 HCl
TMIJ-0230
Oseltamivir EP Impurity C-d3 HCl is a deuterated compound of Oseltamivir EP Impurity C HCl. Oseltamivir EP Impurity C HCl has a CAS number of 1415963-60-8. Oseltamivir carboxylate is an active metabolite of oseltamivir phosphate (Tamiflu).
  • Inquiry Price
20 days
Size
QTY
Neostigmine Bromide EP Impurity C-d6
TMIJ-05042470126-73-7
Neostigmine Bromide EP Impurity C-d6 is a deuterated compound of Neostigmine Bromide EP Impurity C. Neostigmine Bromide EP Impurity C has a CAS number of 16088-19-0.
  • Inquiry Price
20 days
Size
QTY